Suppr超能文献

IgM 抗体介导获得性血管性血友病综合征的不同机制及重组血管性血友病因子在一例患者中的成功治疗。

Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient.

机构信息

Department of Hematology and Oncology, Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.

Medilys Laborgesellschaft mbH, Asklepios Klinik Hamburg-Altona, Hamburg, Germany.

出版信息

Acta Haematol. 2022;145(4):454-457. doi: 10.1159/000522236. Epub 2022 Jan 27.

Abstract

Acquired von Willebrand Syndrome (AVWS) is a rare coagulation disorder which can be associated with IgM paraproteinaemia. Recently, recombinant von Willebrand factor (rVWF) has become available for the treatment of bleedings in patients with inherited von Willebrand disease, but experience in patients with AVWS is limited. We report on 2 patients with AVWS with underlying IgM paraproteinaemia with distinct underlying pathomechanisms. In 1 patient, the paraprotein built unspecific complexes with von Willebrand factor (VWF). In the other patient, we were able to detect an IgM antibody against VWF. Bleeding in this patient was successfully treated with rVWF. To our knowledge, this is the first report about the successful use of rVWF in a patient with AVWS with the detection of a VWF-specific antibody.

摘要

获得性血管性血友病综合征(AVWS)是一种罕见的凝血障碍,可与 IgM 副蛋白血症相关。最近,重组血管性血友病因子(rVWF)已可用于治疗遗传性血管性血友病患者的出血,但 AVWS 患者的经验有限。我们报告了 2 例伴有基础 IgM 副蛋白血症的 AVWS 患者,其潜在的病理机制不同。在 1 例患者中,副蛋白与血管性血友病因子(VWF)形成非特异性复合物。在另一名患者中,我们能够检测到针对 VWF 的 IgM 抗体。该患者的出血成功地用 rVWF 治疗。据我们所知,这是首例报道在检测到 VWF 特异性抗体的情况下,rVWF 在 AVWS 患者中成功应用的病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1df9/9501758/f7ee826f65ac/aha-0145-0454-g01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验